Moderna (MRNA) had the best year in Q2 2021 by a US stock in the S&P 500 (GSPC) in 2021, returning 77.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Moderna (MRNA) | 2021 | 77.75% |
NVIDIA (NVDA) | 2021 | 47.41% |
Targa Resources (TRGP) | 2021 | 38.96% |
Devon Energy (DVN) | 2021 | 33.15% |
Crowdstrike (CRWD) | 2021 | 33.13% |
Pool (POOL) | 2021 | 32.9% |
Equifax (EFX) | 2021 | 32.35% |
Gartner (IT) | 2021 | 31.56% |
Blackstone (BX) | 2021 | 30.21% |
IDEXX Laboratories (IDXX) | 2021 | 29.55% |
Genesis Healthcare (GEN) | 2021 | 27.64% |
Fortinet (FTNT) | 2021 | 27.53% |
ResMed (RMD) | 2021 | 27.24% |
EPAM Systems (EPAM) | 2021 | 27.22% |
Diamondback Energy (FANG) | 2021 | 27.21% |
Charles River Laboratories (CRL) | 2021 | 26.68% |
West Pharmaceutical Services (WST) | 2021 | 26.53% |
Domino’s Pizza (DPZ) | 2021 | 26.34% |
Intuit (INTU) | 2021 | 26.21% |
MSCI (MSCI) | 2021 | 26.05% |
Generac (GNRC) | 2021 | 25.8% |
Marathon Oil (MRO) | 2021 | 24.56% |
Discover Financial Services (DFS) | 2021 | 24.27% |
IQVIA (IQV) | 2021 | 24.25% |
Biogen (BIIB) | 2021 | 23.67% |
